Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Other Working Capital Changes (2016 - 2026)

Ovid Therapeutics filings provide 11 years of Other Working Capital Changes readings, the most recent being -$110000.0 for Q1 2026.

  • Quarterly Other Working Capital Changes fell 283.33% to -$110000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Mar 2026, down 10857.14% year-over-year, with the annual reading at -$1.3 million for FY2025, 48.61% down from the prior year.
  • Other Working Capital Changes hit -$110000.0 in Q1 2026 for Ovid Therapeutics, up from -$1.7 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.7 million in Q3 2023 and bottomed at -$1.7 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is -$62899.5, with a median of -$110000.0 recorded in 2026.
  • The largest annual shift saw Other Working Capital Changes skyrocketed 2362.38% in 2023 before it tumbled 395.16% in 2024.
  • Ovid Therapeutics' Other Working Capital Changes stood at -$265513.0 in 2022, then tumbled by 230.3% to -$877000.0 in 2023, then dropped by 2.51% to -$899000.0 in 2024, then plummeted by 88.21% to -$1.7 million in 2025, then skyrocketed by 93.5% to -$110000.0 in 2026.
  • Per Business Quant, the three most recent readings for OVID's Other Working Capital Changes are -$110000.0 (Q1 2026), -$1.7 million (Q4 2025), and -$522000.0 (Q3 2025).